This session will review Good Clinical Practices, Good Documentation Practices, training and quality, including Key Performance Indicators. In addition, personal data protection will be briefly discussed vis-à-vis HIPPAA.

参加申し込み

Pragmatic Approaches to Drug Safety Across the Premarketing and Postmarketing Continuum

Session 15: Good Clinical Practices and Quality Indicators

Session Chair(s)

JP Clement, MD

最新情報や機会を逃さないで